TWiV 941: Clinical update with Dr. Daniel Griffin
This Week in Virology
00:00
Do You Have Long COVID?
Daniel Griffin: I'm not sure how much I can add to what you brought in. There was some early excitement, that femotidine would be this early treatment for COVID. And there is actually, as you'll see in some of the literature, a subtype which really looks like it's an allergic subtype. William writes about using high dose influenza vaccine in immunocompromised patients under 65 years old. Is this a good idea? This is the first year that the CDC has come out with preferential recommendations on the vaccines.
Transcript
Play full episode
